Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CDC25B | P30305 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | MMP12 | P39900 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | TDO2 | P48775 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4415882 | 1.00 | ALDH1A1 (0.45) | ALDH1A1MAPK1L3MBTL1GLALMNA | |
| SCHEMBL12086008 | 1.00 | ALDH1A1 (0.45) | ALDH1A1MAPK1L3MBTL1GLALMNA | |
| SCHEMBL22817371 | 0.92 | ALDH1A1 (0.43) | ALDH1A1MAPK1L3MBTL1GLALMNA | |
| SCHEMBL11957429 | 0.87 | ALDH1A1 (0.43) | ALDH1A1MAPK1L3MBTL1GLALMNA | |
| SCHEMBL9886347 | 0.86 | GLA (0.55) | ALDH1A1MAPK1L3MBTL1GLACDC25B | |
| SCHEMBL4413019 | 0.86 | GLA (0.55) | ALDH1A1MAPK1L3MBTL1GLACDC25B | |
| SCHEMBL9917628 | 0.86 | GLA (0.55) | ALDH1A1MAPK1L3MBTL1GLACDC25B | |
| SCHEMBL22817417 | 0.84 | MEN1 (0.34) | GLAKMT2A | |
| SCHEMBL9886333 | 0.84 | MEN1 (0.34) | GLAKMT2A | |
| SCHEMBL14901058 | 0.81 | KMT2A (0.38) | ALDH1A1LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260027218-A1 | STAR-SHAPED GRAFT COPOLYMERS | POLYPEPTIDE THERAPEUTIC SOLUTIONS S L (ES) | 2026-01-29 | — | — | US | disclosed |
| EP-4532586-A1 | STAR-SHAPED GRAFT COPOLYMERS | Polypeptide Therapeutic Solutions, S.L. (ES) | 2025-04-09 | — | — | EP | disclosed |
| CN-119591349-A | Wear-resistant porous brick material and preparation method thereof | 武汉市新明亮建筑材料有限责任公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-119585343-A | Star graft copolymers | 多肽治疗解决公司 | 2025-03-07 | — | — | CN | disclosed |
| EP-4425181-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | Bertis Inc (KR) | 2024-09-04 | — | — | EP | disclosed |
| CN-117860908-A | Double-drug nano-drug delivery system with cisplatin drug and proteinase K coupled and preparation method thereof | 浙江大学长三角智慧绿洲创新中心 | 2024-04-12 | — | — | CN | disclosed |
| US-20240109875-A1 | NOVEL METHOD FOR SYNTHESIZING NCA COMPOUNDS | ECOLE NATIONALE SUPERIEURE DE CHIMIE DE MONTPELLIER (ENSCM) (FR) | 2024-04-04 | — | — | US | disclosed |
| US-20240011979-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS INC. (KR) | 2024-01-11 | — | — | US | disclosed |
| WO-2023227724-A1 | STAR-SHAPED GRAFT COPOLYMERS | POLYPEPTIDE THERAPEUTIC SOLUTIONS, S.L. (ES) | 2023-11-30 | — | — | WO | disclosed |
| WO-2023227724-A1 | STAR-SHAPED GRAFT COPOLYMERS | POLYPEPTIDE THERAPEUTIC SOLUTIONS, S.L. (ES) | 2023-11-30 | — | — | WO | disclosed |
| US-20090092554-A1 | ENCAPSULATED CONTRAST AGENTS | INTEZYNE TECHNOLOGIES, INC. (US) | 2009-04-09 | — | — | US | disclosed |
| US-20080274173-A1 | Copolymer of crosslinkable or crosslinked poly(amino acid block), and a hydrophobic D,L-mixed poly(amino acid) block; an inner core, crosslinked outer core, a hydrophilic shell; improved in vivo circulation time; drug delivery | INTEZYNE TECHNOLOGIES, INC. (US) | 2008-11-06 | — | — | US | disclosed |
| US-20080274173-A1 | Copolymer of crosslinkable or crosslinked poly(amino acid block), and a hydrophobic D,L-mixed poly(amino acid) block; an inner core, crosslinked outer core, a hydrophilic shell; improved in vivo circulation time; drug delivery | INTEZYNE TECHNOLOGIES, INC. (US) | 2008-11-06 | — | — | US | disclosed |
| WO-2008134734-A2 | ENCAPSULATED CONTRAST AGENTS | INTEZYNE TECHNOLOGIES, INC. (US) | 2008-11-06 | — | — | WO | disclosed |
| WO-2008134731-A1 | HYBRID BLOCK COPOLYMER MICELLES WITH MIXED STEREOCHEMISTRY FOR ENCAPSULATION OF HYDROPHOBIC AGENTS | INTEZYNE TECHNOLOGIES, INC. (US) | 2008-11-06 | — | — | WO | disclosed |
| US-7294719-B2 | Synthesis of amino acid, N-carboxyanhydrides | SIGMA-ALDRICH CO. (US) | 2007-11-13 | — | — | US | disclosed |
| US-7294719-B2 | Synthesis of amino acid, N-carboxyanhydrides | SIGMA-ALDRICH CO. (US) | 2007-11-13 | — | — | US | disclosed |
| US-6670447-B2 | An 3-acyl-4-substituted-oxazolidin-2,5-dione that readily reacts with nucleophilic reagents such as free amino acids; use in peptide synthesis for example | MITSUI CHEMICALS, INC. (JP) | 2003-12-30 | — | — | US | disclosed |
| EP-1298127-A1 | AMINO ACID-N-CARBOXY ANHYDRIDES HVAING SUBSTITUENT AT NITROGEN | Mitsui Chemicals, Inc. (JP) | 2003-04-02 | — | — | EP | disclosed |
| US-20020173664-A1 | Amino acid-n-carboxy anhydrides hvaing substituent at nitrogen | MITSUI CHEMICALS, INC. (JP) | 2002-11-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260027218-A1 | STAR-SHAPED GRAFT COPOLYMERS | RHOA, PCNA, HBZ | ALDH1A1 4727/4885MAPK1 2042/4885L3MBTL1 1255/4885 |
| US-20240109875-A1 | NOVEL METHOD FOR SYNTHESIZING NCA COMPOUNDS | NPPA, NGLY1, NAAA | ALDH1A1 4529/4885MAPK1 2175/4885L3MBTL1 3696/4885 |
| US-20090092554-A1 | ENCAPSULATED CONTRAST AGENTS | LIPA, LPXN, CD47 | ALDH1A1 3588/4885MAPK1 4603/4885L3MBTL1 3615/4885 |
| US-20020173664-A1 | Amino acid-n-carboxy anhydrides hvaing substituent at nitrogen | DNPEP, HDGF, ANPEP | ALDH1A1 702/4885MAPK1 1495/4885L3MBTL1 4223/4885 |
| US-20080274173-A1 | Copolymer of crosslinkable or crosslinked poly(amino acid block), and a hydrophobic D,L-mixed poly(amino acid) block; an inner core, crosslinked outer core, a hydrophilic shell; improved in vivo circulation time; drug delivery | CLTB, SLC1A5, CLTA | ALDH1A1 3966/4885MAPK1 4597/4885L3MBTL1 647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.